These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19365955)

  • 1. [Prenatal genetic screening: biochemical markers of the first and second quarter].
    Grether González P; Aguinaga Ríos M;
    Ginecol Obstet Mex; 2009 Feb; 77(2):S27-46. PubMed ID: 19365955
    [No Abstract]   [Full Text] [Related]  

  • 2. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
    Jørgensen FS
    Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
    [No Abstract]   [Full Text] [Related]  

  • 4. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal maternal serum screening during the second trimester of pregnancy using the Triple Test in Luxembourg.
    Thix J
    Bull Soc Sci Med Grand Duche Luxemb; 2006; (3):387-405. PubMed ID: 17209295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening tests facilitate risk assessment.
    Miller SM; Isabel JM
    MLO Med Lab Obs; 2002 Feb; 34(2):8-11, 14-6, 19; quiz 20-1. PubMed ID: 11881274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal screening for birth defects: an update.
    Morris K
    Mo Med; 2004; 101(2):121-4. PubMed ID: 15119110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal genetic screening.
    Grant SS
    Online J Issues Nurs; 2000; 5(3):2. PubMed ID: 11380268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
    Skotko B
    Obstet Gynecol; 2006 May; 107(5):1170. PubMed ID: 16648429
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical screening for congenital defects.
    Bahado-Singh RO; Sutton-Riley J
    Obstet Gynecol Clin North Am; 2004 Dec; 31(4):857-72, xi. PubMed ID: 15550339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining first and second trimester markers for Down syndrome screening: think twice.
    Cocciolone R; Brameld K; O'Leary P; Haan E; Muller P; Shand K
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated screening for Down's syndrome.
    Reynolds T; Zimmermann R; Wright E
    N Engl J Med; 1999 Dec; 341(25):1935; author reply 1936. PubMed ID: 10610478
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
    Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
    AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-trimester maternal serum screening for Down syndrome in Mainland China.
    Liao C; Huang Y; Li D; Song S; Yi C; Zhou J
    Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
    Wyatt P
    Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal serum screening.
    Lofsky S
    CMAJ; 1999 Apr; 160(8):1125-6. PubMed ID: 10234332
    [No Abstract]   [Full Text] [Related]  

  • 19. [Specificity of biochemical markers of pregnancy second trimester].
    Salazar López R; Ibarra Gallardo AL; Iduma Meléndrez M; Leyva Bojórquez R
    Ginecol Obstet Mex; 2007 Oct; 75(10):608-14. PubMed ID: 18800579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncation limits for CT marker ratios in prenatal screening for Down syndrome.
    Wald NJ; Bestwick JP; Morris JK
    Prenat Diagn; 2007 Feb; 27(2):187-8. PubMed ID: 17266161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.